At a Glance
TTK Healthcare—home to gripe water, deodorants, condoms, and a whiff of nostalgia—just dropped its Q1 FY26 report. Revenue clocked ₹226.43 Cr (Rs 22,643 Lakh) and net profit came in at ₹13 Cr, but the market yawned, dragging the stock down 3.55% to ₹1,216. Operating profit margin? A barely-there 1%. Despite being “almost debt-free” and flaunting a 42% 5-year profit CAGR, sales growth crawled at 4.4%. This is the corporate version of a six-pack body with the stamina of a sloth.
Introduction
TTK Healthcare is that quirky relative at the family function—diversified, unpredictable, and occasionally impressive. From baby care to sexual wellness, this company sells products covering all stages of life. But FY26 kicked off with a reality check: falling quarterly profit (-20% YoY), rising costs, and an operating margin so thin it could double as tracing paper.
The stock’s P/E sits at a “meh” 24.1—neither bargain nor bubble—while peers like 3M India laugh with a P/E of 72. With promoters clutching 74.57% stake like it’s their heirloom, public investors are left with the crumbs (22%). Will Q1 be a blip or the start of a slow gripe? Let’s peel the layers.
Business Model (WTF Do They Even Do?)
TTK Healthcare operates across five segments—pharmaceuticals, consumer products, medical devices, protective devices, and foods. This is less “focused corporate strategy” and more “throw everything at the wall and see what sticks.”
- Consumer Products (31% revenue): Eva deodorants for the teenagers, Skore condoms for when the deodorant works, and Woodward’s Gripe Water for when the result of that combination cries at 3 AM.
- Medical Devices & Protective Devices: Think heart valves and surgical tools, because someone needs to fix the consequences of bad life decisions.
- Pharmaceuticals: A small but stable line-up of drugs.
- Foods: Minimal, because who trusts a gripe water company for dinner ideas?
This cocktail of businesses helps spread risk, but also ensures they never fully dominate any single category.
Financials Overview
Q1 FY26 Snapshot:
- Revenue: ₹226.43 Cr (+8.9% YoY)
- Net
